Michael P. Dube, VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA), sold 2,012 shares at $19.01 ($38K) on 2024-10-02, disclosed to the SEC on 2024-10-04.
Open-market sale of $38k NTLA by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2026-01-07 | $28K | — | Filing → |
| NTLA | SELL | 2025-10-03 | $33K | — | Filing → |
| NTLA | SELL | 2025-07-03 | $25K | — | Filing → |